Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients

Morgane Roulot,1,&dagger; Alessandra Minelli,2 Marco Bortolomasi,3 Elisabetta Maffioletti,2,4 Massimo Gennarelli,2,4 Marc Borsotto,1 Catherine Heurteaux,1 Jean Mazella1 1Molecular and Cellular Institute of Pharmacology, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Roulot M, Minelli A, Bortolomasi M, Maffioletti E, Gennarelli M, Borsotto M, Heurteaux C, Mazella J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	sortilin propeptide electroconvulsive therapy treatment resistant depressed patients diagnosis Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/9a2e4ce36679435ea3e688402f8dc94f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients

Ejemplares similares